Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health.


Latest Articles

Global Language Academy

One global learning platform for languages, countless opportunities to grow your career

Our Italian colleague Lorenzo learned German via our Global Language Academy

Ukrainian flag
Corporate Profile

Solidarity with Ukraine

We condemn military aggression against Ukraine and will contribute EUR 38 million to humanitarian relief funds for Ukraine. 


Read more Opens in new tab
Family at the beach

Annual Report 2022: Generations

Our aim is to transform lives, today and for generations to come. In this annual report, our employees share amazing success stories about how, through their work, they contribute to a better and healthier world of humans and animals.


Related Press Releases